00559nas a2200229   4500000000100000008004100001100001500042700001300057700001300070700001000083700001200093700001700105700001200122700001400134700001600148700001300164700001900177245009900196250001700295300001000312490000700322       2014                            d1 ade Zeeuw D1 aYamout H1 aDavies M1 aWoo V1 aMayer C1 aVijapurkar U1 aKline I1 aUsiskin K1 aMeininger G1 aBakris G1 aPerkovic Vlado00aEfficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.  a2014 July 17  a64-740 v40